|
Chris Metzler, DPM 
Director of Quality Standards
Dr. Christopher Metzler has extensive experience in global pharmacovigilance and drug information systems compliance and auditing. He is responsible for the Sentrx regulated document system; process improvement initiatives; and responses to client, health authority and business partner audits.
Prior to joining Sentrx, Dr. Metzler was Audit Manager for Wyeth Pharmaceuticals' Global Business Compliance group. There he was responsible for auditing headquarters, affiliates, and business partners for pharmacovigilance, privacy, labeling and medical information practices against international laws and regulations and company policies and procedures. During his tenure, he audited more than 200 drug safety SOPs and maintained an excellent level of understanding of current global pharmacovigilance legislation and guidance.
Dr. Metzler also spent nearly five years with Schering-Plough Corporation, holding positions of increasing responsibility in Drug Safety Surveillance Compliance, Operations and Training. As Senior Global Drug Information Services Compliance Manager, Dr. Metzler oversaw audits, SOP development and compliance, training and medical inquiry support.
Prior to entering the pharmaceutical industry, Dr. Metzler was a pharmacist and a practicing podiatrist. He graduated from Rutgers College of Pharmacy in 1984 and from New York College of Podiatric Medicine in 1989. He holds NJ licenses for Podiatry and for Pharmacy, and he is certified by the American Board of Podiatric Orthopedics.
|
